AngioDynamics (ANGO) Tops Q3 EPS by 4c, Reaffirms FY Guidance

AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.03, $0.04 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $74 million versus the consensus estimate of $76.32 million.

GUIDANCE:

AngioDynamics sees FY2022 EPS of ($0.02)-$0.02, versus the consensus of ($0.01). AngioDynamics sees FY2022 revenue of $310-315 million, versus the consensus of $313.7 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49